At a glance
ClinicalIndex Comparison RecordN/ACompleted· 23 enrolled
Drug / intervention
The Imperial College Closed-Loop Insulin Delivery System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Assessment of a Closed-loop Insulin Delivery System
In Brief
A clinical study evaluating The Imperial College Closed-Loop Insulin Delivery System and Open loop for Type 1 Diabetes Mellitus. Completed, enrolled 23 participants across 1 site.
Detailed Summary
The purpose of the study is to assess the safety and efficacy of the Imperial College closed loop insulin delivery system (artificial pancreas) in subjects with type 1 diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
First PostedFeb 2012
Primary CompletionAug 2014
Study CompletionAug 2018
TodayJul 2026
First PostedFeb 16, 2012
Enrollment StartAug 1, 2011
Primary CompletionAug 1, 2014
Study CompletionAug 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 14.4 years ago
Interventions
The Imperial College Closed-Loop Insulin Delivery Systemdevice
The Imperial College closed-loop insulin delivery system comprises 3 main components: the glucose sensor, the control algorithm and the insulin delivery system.
Open loopdevice
glucose sensor and pump